nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.416	1	CrCtD
Levonorgestrel—PGR—Betamethasone—systemic lupus erythematosus	0.0566	0.243	CbGbCtD
Levonorgestrel—SHBG—Hydrocortisone—systemic lupus erythematosus	0.0508	0.218	CbGbCtD
Levonorgestrel—PGR—Dexamethasone—systemic lupus erythematosus	0.0329	0.141	CbGbCtD
Levonorgestrel—CYP19A1—Betamethasone—systemic lupus erythematosus	0.0319	0.137	CbGbCtD
Levonorgestrel—Danazol—Hydrocortisone—systemic lupus erythematosus	0.0228	0.0897	CrCrCtD
Levonorgestrel—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.0198	0.078	CrCrCtD
Levonorgestrel—Danazol—Prednisone—systemic lupus erythematosus	0.0196	0.0773	CrCrCtD
Levonorgestrel—CYP19A1—Dexamethasone—systemic lupus erythematosus	0.0185	0.0794	CbGbCtD
Levonorgestrel—Progesterone—Hydrocortisone—systemic lupus erythematosus	0.0167	0.0657	CrCrCtD
Levonorgestrel—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.0167	0.0657	CrCrCtD
Levonorgestrel—Methyltestosterone—Hydrocortisone—systemic lupus erythematosus	0.0163	0.0641	CrCrCtD
Levonorgestrel—Testosterone—Hydrocortisone—systemic lupus erythematosus	0.0145	0.057	CrCrCtD
Levonorgestrel—Progesterone—Prednisolone—systemic lupus erythematosus	0.014	0.0552	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisone—systemic lupus erythematosus	0.014	0.0552	CrCrCtD
Levonorgestrel—Methyltestosterone—Prednisolone—systemic lupus erythematosus	0.0137	0.0538	CrCrCtD
Levonorgestrel—Hydrocortisone—Methylprednisolone—systemic lupus erythematosus	0.0128	0.0506	CrCrCtD
Levonorgestrel—Hydrocortisone—Dexamethasone—systemic lupus erythematosus	0.0126	0.0498	CrCrCtD
Levonorgestrel—Hydrocortisone—Betamethasone—systemic lupus erythematosus	0.0126	0.0498	CrCrCtD
Levonorgestrel—Hydrocortisone—Triamcinolone—systemic lupus erythematosus	0.0123	0.0486	CrCrCtD
Levonorgestrel—Testosterone—Prednisolone—systemic lupus erythematosus	0.0122	0.0479	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisone—systemic lupus erythematosus	0.0117	0.0461	CrCrCtD
Levonorgestrel—Hydrocortisone—Prednisolone—systemic lupus erythematosus	0.0114	0.045	CrCrCtD
Levonorgestrel—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00621	0.0266	CbGbCtD
Levonorgestrel—CYP3A4—Dapsone—systemic lupus erythematosus	0.00543	0.0232	CbGbCtD
Levonorgestrel—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0047	0.0202	CbGbCtD
Levonorgestrel—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0047	0.0202	CbGbCtD
Levonorgestrel—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00404	0.0173	CbGbCtD
Levonorgestrel—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00398	0.0171	CbGbCtD
Levonorgestrel—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00377	0.0162	CbGbCtD
Levonorgestrel—CYP3A4—Prednisone—systemic lupus erythematosus	0.00376	0.0161	CbGbCtD
Levonorgestrel—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00356	0.0153	CbGbCtD
Levonorgestrel—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00235	0.0101	CbGbCtD
Levonorgestrel—SHBG—blood plasma—systemic lupus erythematosus	0.000849	0.083	CbGeAlD
Levonorgestrel—SRD5A1—nervous system—systemic lupus erythematosus	0.000693	0.0678	CbGeAlD
Levonorgestrel—SRD5A1—central nervous system—systemic lupus erythematosus	0.000668	0.0653	CbGeAlD
Levonorgestrel—CYP3A4—urine—systemic lupus erythematosus	0.000639	0.0625	CbGeAlD
Levonorgestrel—SHBG—connective tissue—systemic lupus erythematosus	0.000452	0.0442	CbGeAlD
Levonorgestrel—PGR—connective tissue—systemic lupus erythematosus	0.000407	0.0398	CbGeAlD
Levonorgestrel—Danazol—CCL2—systemic lupus erythematosus	0.000393	0.564	CrCbGaD
Levonorgestrel—CYP19A1—connective tissue—systemic lupus erythematosus	0.000366	0.0358	CbGeAlD
Levonorgestrel—CYP3A4—blood plasma—systemic lupus erythematosus	0.000334	0.0326	CbGeAlD
Levonorgestrel—AR—connective tissue—systemic lupus erythematosus	0.000324	0.0317	CbGeAlD
Levonorgestrel—ESR1—connective tissue—systemic lupus erythematosus	0.000318	0.0311	CbGeAlD
Levonorgestrel—SHBG—bone marrow—systemic lupus erythematosus	0.000301	0.0294	CbGeAlD
Levonorgestrel—PGR—lymphoid tissue—systemic lupus erythematosus	0.000298	0.0291	CbGeAlD
Levonorgestrel—AR—skin of body—systemic lupus erythematosus	0.000293	0.0286	CbGeAlD
Levonorgestrel—AR—kidney—systemic lupus erythematosus	0.000276	0.027	CbGeAlD
Levonorgestrel—ESR1—kidney—systemic lupus erythematosus	0.000271	0.0265	CbGeAlD
Levonorgestrel—AR—cortex of kidney—systemic lupus erythematosus	0.000269	0.0263	CbGeAlD
Levonorgestrel—PGR—lung—systemic lupus erythematosus	0.000246	0.024	CbGeAlD
Levonorgestrel—SHBG—central nervous system—systemic lupus erythematosus	0.000243	0.0238	CbGeAlD
Levonorgestrel—AR—lymphoid tissue—systemic lupus erythematosus	0.000237	0.0232	CbGeAlD
Levonorgestrel—ESR1—lymphoid tissue—systemic lupus erythematosus	0.000233	0.0228	CbGeAlD
Levonorgestrel—PGR—nervous system—systemic lupus erythematosus	0.000227	0.0222	CbGeAlD
Levonorgestrel—AR—tendon—systemic lupus erythematosus	0.000223	0.0218	CbGeAlD
Levonorgestrel—PGR—central nervous system—systemic lupus erythematosus	0.000219	0.0214	CbGeAlD
Levonorgestrel—CYP19A1—nervous system—systemic lupus erythematosus	0.000205	0.02	CbGeAlD
Levonorgestrel—CYP19A1—central nervous system—systemic lupus erythematosus	0.000197	0.0193	CbGeAlD
Levonorgestrel—AR—lung—systemic lupus erythematosus	0.000196	0.0191	CbGeAlD
Levonorgestrel—ESR1—lung—systemic lupus erythematosus	0.000192	0.0188	CbGeAlD
Levonorgestrel—AR—nervous system—systemic lupus erythematosus	0.000181	0.0177	CbGeAlD
Levonorgestrel—ESR1—nervous system—systemic lupus erythematosus	0.000178	0.0174	CbGeAlD
Levonorgestrel—AR—central nervous system—systemic lupus erythematosus	0.000174	0.0171	CbGeAlD
Levonorgestrel—ESR1—central nervous system—systemic lupus erythematosus	0.000171	0.0167	CbGeAlD
Levonorgestrel—CYP3A4—kidney—systemic lupus erythematosus	0.000151	0.0148	CbGeAlD
Levonorgestrel—CYP3A4—nervous system—systemic lupus erythematosus	9.92e-05	0.00971	CbGeAlD
Levonorgestrel—CYP3A4—central nervous system—systemic lupus erythematosus	9.55e-05	0.00934	CbGeAlD
Levonorgestrel—Hydrocortisone—NR3C1—systemic lupus erythematosus	8.47e-05	0.122	CrCbGaD
Levonorgestrel—Progesterone—NR3C1—systemic lupus erythematosus	6.9e-05	0.0991	CrCbGaD
Levonorgestrel—Norethindrone—ALB—systemic lupus erythematosus	5.99e-05	0.086	CrCbGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—CD4—systemic lupus erythematosus	5.89e-05	0.00456	CbGpPWpGaD
Levonorgestrel—AR—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	5.83e-05	0.00452	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL10—systemic lupus erythematosus	5.8e-05	0.0045	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—systemic lupus erythematosus	5.7e-05	0.00441	CbGpPWpGaD
Levonorgestrel—Methyltestosterone—ALB—systemic lupus erythematosus	5.69e-05	0.0816	CrCbGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL4—systemic lupus erythematosus	5.65e-05	0.00437	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	5.59e-05	0.00433	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	5.55e-05	0.0043	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—CDKN1B—systemic lupus erythematosus	5.53e-05	0.00429	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—C3—systemic lupus erythematosus	5.51e-05	0.00427	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—NOS3—systemic lupus erythematosus	5.49e-05	0.00425	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—NR3C1—systemic lupus erythematosus	5.37e-05	0.00416	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	5.36e-05	0.00415	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	5.31e-05	0.00411	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—JAK1—systemic lupus erythematosus	5.24e-05	0.00406	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	5.16e-05	0.004	CbGpPWpGaD
Levonorgestrel—AR—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	5.12e-05	0.00397	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—JAK1—systemic lupus erythematosus	5.08e-05	0.00393	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—NAT2—systemic lupus erythematosus	5.04e-05	0.0039	CbGpPWpGaD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—EP300—systemic lupus erythematosus	4.98e-05	0.00386	CbGpPWpGaD
Levonorgestrel—AR—Notch-mediated HES/HEY network—EP300—systemic lupus erythematosus	4.86e-05	0.00376	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	4.81e-05	0.00373	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—systemic lupus erythematosus	4.78e-05	0.0037	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.64e-05	0.00359	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	4.58e-05	0.00355	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	4.49e-05	0.00348	CbGpPWpGaD
Levonorgestrel—AR—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	4.41e-05	0.00342	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—systemic lupus erythematosus	4.4e-05	0.00341	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	4.37e-05	0.00339	CbGpPWpGaD
Levonorgestrel—Loss of consciousness—Betamethasone—systemic lupus erythematosus	4.37e-05	0.000601	CcSEcCtD
Levonorgestrel—Rash—Leflunomide—systemic lupus erythematosus	4.37e-05	0.0006	CcSEcCtD
Levonorgestrel—Dermatitis—Leflunomide—systemic lupus erythematosus	4.36e-05	0.0006	CcSEcCtD
Levonorgestrel—Mental disorder—Prednisone—systemic lupus erythematosus	4.36e-05	0.000599	CcSEcCtD
Levonorgestrel—Nausea—Azathioprine—systemic lupus erythematosus	4.36e-05	0.000599	CcSEcCtD
Levonorgestrel—Headache—Leflunomide—systemic lupus erythematosus	4.34e-05	0.000597	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	4.34e-05	0.00336	CbGpPWpGaD
Levonorgestrel—Skin disorder—Methylprednisolone—systemic lupus erythematosus	4.34e-05	0.000596	CcSEcCtD
Levonorgestrel—Malnutrition—Prednisone—systemic lupus erythematosus	4.33e-05	0.000595	CcSEcCtD
Levonorgestrel—Erythema—Prednisone—systemic lupus erythematosus	4.33e-05	0.000595	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	4.33e-05	0.000595	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	4.33e-05	0.000595	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	4.32e-05	0.000593	CcSEcCtD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	4.31e-05	0.00334	CbGpPWpGaD
Levonorgestrel—Insomnia—Hydrocortisone—systemic lupus erythematosus	4.3e-05	0.000591	CcSEcCtD
Levonorgestrel—Hypertension—Betamethasone—systemic lupus erythematosus	4.29e-05	0.00059	CcSEcCtD
Levonorgestrel—Hypertension—Dexamethasone—systemic lupus erythematosus	4.29e-05	0.00059	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.26e-05	0.000586	CcSEcCtD
Levonorgestrel—Urticaria—Cyclosporine—systemic lupus erythematosus	4.25e-05	0.000584	CcSEcCtD
Levonorgestrel—Myalgia—Dexamethasone—systemic lupus erythematosus	4.23e-05	0.000582	CcSEcCtD
Levonorgestrel—Myalgia—Betamethasone—systemic lupus erythematosus	4.23e-05	0.000582	CcSEcCtD
Levonorgestrel—Abdominal pain—Cyclosporine—systemic lupus erythematosus	4.23e-05	0.000581	CcSEcCtD
Levonorgestrel—Body temperature increased—Cyclosporine—systemic lupus erythematosus	4.23e-05	0.000581	CcSEcCtD
Levonorgestrel—Anxiety—Dexamethasone—systemic lupus erythematosus	4.22e-05	0.00058	CcSEcCtD
Levonorgestrel—Anxiety—Betamethasone—systemic lupus erythematosus	4.22e-05	0.00058	CcSEcCtD
Levonorgestrel—Discomfort—Betamethasone—systemic lupus erythematosus	4.18e-05	0.000575	CcSEcCtD
Levonorgestrel—Discomfort—Dexamethasone—systemic lupus erythematosus	4.18e-05	0.000575	CcSEcCtD
Levonorgestrel—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	4.18e-05	0.000575	CcSEcCtD
Levonorgestrel—Haemoglobin—Methotrexate—systemic lupus erythematosus	4.18e-05	0.000575	CcSEcCtD
Levonorgestrel—Pain—Prednisolone—systemic lupus erythematosus	4.16e-05	0.000572	CcSEcCtD
Levonorgestrel—Haemorrhage—Methotrexate—systemic lupus erythematosus	4.16e-05	0.000572	CcSEcCtD
Levonorgestrel—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	4.14e-05	0.00057	CcSEcCtD
Levonorgestrel—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.13e-05	0.000568	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—SNRPD1—systemic lupus erythematosus	4.13e-05	0.0032	CbGpPWpGaD
Levonorgestrel—Pharyngitis—Methotrexate—systemic lupus erythematosus	4.13e-05	0.000567	CcSEcCtD
Levonorgestrel—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.12e-05	0.000567	CcSEcCtD
Levonorgestrel—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.12e-05	0.000567	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—CXCL12—systemic lupus erythematosus	4.12e-05	0.00319	CbGpPWpGaD
Levonorgestrel—Nausea—Leflunomide—systemic lupus erythematosus	4.11e-05	0.000566	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.11e-05	0.000565	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.1e-05	0.000564	CcSEcCtD
Levonorgestrel—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.1e-05	0.000563	CcSEcCtD
Levonorgestrel—ESR1—FOXM1 transcription factor network—EP300—systemic lupus erythematosus	4.1e-05	0.00317	CbGpPWpGaD
Levonorgestrel—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.08e-05	0.00056	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.08e-05	0.00056	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.07e-05	0.000559	CcSEcCtD
Levonorgestrel—Pain—Hydrocortisone—systemic lupus erythematosus	4.06e-05	0.000558	CcSEcCtD
Levonorgestrel—Oedema—Betamethasone—systemic lupus erythematosus	4.06e-05	0.000558	CcSEcCtD
Levonorgestrel—Oedema—Dexamethasone—systemic lupus erythematosus	4.06e-05	0.000558	CcSEcCtD
Levonorgestrel—Insomnia—Triamcinolone—systemic lupus erythematosus	4.05e-05	0.000556	CcSEcCtD
Levonorgestrel—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.04e-05	0.000555	CcSEcCtD
Levonorgestrel—Infection—Betamethasone—systemic lupus erythematosus	4.03e-05	0.000554	CcSEcCtD
Levonorgestrel—Infection—Dexamethasone—systemic lupus erythematosus	4.03e-05	0.000554	CcSEcCtD
Levonorgestrel—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	4.02e-05	0.00311	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CCL2—systemic lupus erythematosus	4.01e-05	0.00311	CbGpPWpGaD
Levonorgestrel—Visual impairment—Methotrexate—systemic lupus erythematosus	4.01e-05	0.000551	CcSEcCtD
Levonorgestrel—Anaemia—Prednisone—systemic lupus erythematosus	4e-05	0.00055	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4e-05	0.0031	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	4e-05	0.0031	CbGpPWpGaD
Levonorgestrel—Shock—Betamethasone—systemic lupus erythematosus	3.99e-05	0.000549	CcSEcCtD
Levonorgestrel—Shock—Dexamethasone—systemic lupus erythematosus	3.99e-05	0.000549	CcSEcCtD
Levonorgestrel—Dyspnoea—Triamcinolone—systemic lupus erythematosus	3.99e-05	0.000548	CcSEcCtD
Levonorgestrel—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	3.98e-05	0.000547	CcSEcCtD
Levonorgestrel—Nervous system disorder—Betamethasone—systemic lupus erythematosus	3.98e-05	0.000547	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	3.97e-05	0.00307	CbGpPWpGaD
Levonorgestrel—Angioedema—Prednisone—systemic lupus erythematosus	3.96e-05	0.000544	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—CD80—systemic lupus erythematosus	3.96e-05	0.00307	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	3.95e-05	0.00306	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	3.94e-05	0.000541	CcSEcCtD
Levonorgestrel—Dyspepsia—Triamcinolone—systemic lupus erythematosus	3.94e-05	0.000541	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.93e-05	0.00054	CcSEcCtD
Levonorgestrel—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	3.93e-05	0.00054	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.000539	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	3.92e-05	0.000539	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IFNG—systemic lupus erythematosus	3.91e-05	0.00303	CbGpPWpGaD
Levonorgestrel—Vertigo—Prednisone—systemic lupus erythematosus	3.89e-05	0.000535	CcSEcCtD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	3.89e-05	0.00301	CbGpPWpGaD
Levonorgestrel—Eye disorder—Methotrexate—systemic lupus erythematosus	3.89e-05	0.000534	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.89e-05	0.000534	CcSEcCtD
Levonorgestrel—Syncope—Prednisone—systemic lupus erythematosus	3.88e-05	0.000534	CcSEcCtD
Levonorgestrel—Anorexia—Betamethasone—systemic lupus erythematosus	3.87e-05	0.000532	CcSEcCtD
Levonorgestrel—Anorexia—Dexamethasone—systemic lupus erythematosus	3.87e-05	0.000532	CcSEcCtD
Levonorgestrel—Urticaria—Prednisolone—systemic lupus erythematosus	3.87e-05	0.000531	CcSEcCtD
Levonorgestrel—Cardiac disorder—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000531	CcSEcCtD
Levonorgestrel—Fatigue—Triamcinolone—systemic lupus erythematosus	3.86e-05	0.00053	CcSEcCtD
Levonorgestrel—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.85e-05	0.000529	CcSEcCtD
Levonorgestrel—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	3.84e-05	0.000528	CcSEcCtD
Levonorgestrel—Asthenia—Cyclosporine—systemic lupus erythematosus	3.84e-05	0.000527	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.83e-05	0.00297	CbGpPWpGaD
Levonorgestrel—Pain—Triamcinolone—systemic lupus erythematosus	3.83e-05	0.000526	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	3.81e-05	0.00295	CbGpPWpGaD
Levonorgestrel—Loss of consciousness—Prednisone—systemic lupus erythematosus	3.81e-05	0.000523	CcSEcCtD
Levonorgestrel—Pruritus—Cyclosporine—systemic lupus erythematosus	3.78e-05	0.00052	CcSEcCtD
Levonorgestrel—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.77e-05	0.000519	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000516	CcSEcCtD
Levonorgestrel—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.76e-05	0.000516	CcSEcCtD
Levonorgestrel—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.76e-05	0.000516	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000515	CcSEcCtD
Levonorgestrel—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.74e-05	0.000514	CcSEcCtD
Levonorgestrel—Hypertension—Prednisone—systemic lupus erythematosus	3.74e-05	0.000514	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—MTA2—systemic lupus erythematosus	3.74e-05	0.00289	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—PRL—systemic lupus erythematosus	3.73e-05	0.00289	CbGpPWpGaD
Levonorgestrel—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.7e-05	0.000508	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.7e-05	0.000508	CcSEcCtD
Levonorgestrel—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.69e-05	0.000507	CcSEcCtD
Levonorgestrel—Myalgia—Prednisone—systemic lupus erythematosus	3.69e-05	0.000507	CcSEcCtD
Levonorgestrel—Anxiety—Prednisone—systemic lupus erythematosus	3.68e-05	0.000505	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—systemic lupus erythematosus	3.67e-05	0.000505	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	3.67e-05	0.00285	CbGpPWpGaD
Levonorgestrel—Insomnia—Betamethasone—systemic lupus erythematosus	3.67e-05	0.000505	CcSEcCtD
Levonorgestrel—Insomnia—Dexamethasone—systemic lupus erythematosus	3.67e-05	0.000505	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	3.66e-05	0.000503	CcSEcCtD
Levonorgestrel—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.66e-05	0.000503	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.65e-05	0.000502	CcSEcCtD
Levonorgestrel—Discomfort—Prednisone—systemic lupus erythematosus	3.64e-05	0.000501	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—systemic lupus erythematosus	3.64e-05	0.000501	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—systemic lupus erythematosus	3.62e-05	0.000498	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—systemic lupus erythematosus	3.62e-05	0.000498	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	3.61e-05	0.00279	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.6e-05	0.00279	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—RXRA—systemic lupus erythematosus	3.59e-05	0.00278	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.58e-05	0.000493	CcSEcCtD
Levonorgestrel—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.57e-05	0.000491	CcSEcCtD
Levonorgestrel—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.57e-05	0.000491	CcSEcCtD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	3.57e-05	0.00277	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.57e-05	0.00049	CcSEcCtD
Levonorgestrel—Urticaria—Triamcinolone—systemic lupus erythematosus	3.55e-05	0.000489	CcSEcCtD
Levonorgestrel—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.55e-05	0.000487	CcSEcCtD
Levonorgestrel—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.54e-05	0.000486	CcSEcCtD
Levonorgestrel—Dizziness—Cyclosporine—systemic lupus erythematosus	3.54e-05	0.000486	CcSEcCtD
Levonorgestrel—Oedema—Prednisone—systemic lupus erythematosus	3.54e-05	0.000486	CcSEcCtD
Levonorgestrel—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.53e-05	0.000485	CcSEcCtD
Levonorgestrel—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.53e-05	0.000485	CcSEcCtD
Levonorgestrel—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.53e-05	0.000485	CcSEcCtD
Levonorgestrel—Infection—Prednisone—systemic lupus erythematosus	3.51e-05	0.000483	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.5e-05	0.000482	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.5e-05	0.000482	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—systemic lupus erythematosus	3.5e-05	0.000481	CcSEcCtD
Levonorgestrel—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.5e-05	0.000481	CcSEcCtD
Levonorgestrel—Fatigue—Dexamethasone—systemic lupus erythematosus	3.5e-05	0.000481	CcSEcCtD
Levonorgestrel—Fatigue—Betamethasone—systemic lupus erythematosus	3.5e-05	0.000481	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—IFNG—systemic lupus erythematosus	3.49e-05	0.00271	CbGpPWpGaD
Levonorgestrel—Shock—Prednisone—systemic lupus erythematosus	3.48e-05	0.000478	CcSEcCtD
Levonorgestrel—Pain—Dexamethasone—systemic lupus erythematosus	3.47e-05	0.000477	CcSEcCtD
Levonorgestrel—Pain—Betamethasone—systemic lupus erythematosus	3.47e-05	0.000477	CcSEcCtD
Levonorgestrel—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.47e-05	0.000477	CcSEcCtD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	3.47e-05	0.00269	CbGpPWpGaD
Levonorgestrel—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.45e-05	0.000474	CcSEcCtD
Levonorgestrel—Skin disorder—Prednisone—systemic lupus erythematosus	3.43e-05	0.000472	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.42e-05	0.00047	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—IFNG—systemic lupus erythematosus	3.41e-05	0.00264	CbGpPWpGaD
Levonorgestrel—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.41e-05	0.000469	CcSEcCtD
Levonorgestrel—Vomiting—Cyclosporine—systemic lupus erythematosus	3.4e-05	0.000467	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—NOS3—systemic lupus erythematosus	3.39e-05	0.00262	CbGpPWpGaD
Levonorgestrel—Rash—Cyclosporine—systemic lupus erythematosus	3.37e-05	0.000463	CcSEcCtD
Levonorgestrel—Anorexia—Prednisone—systemic lupus erythematosus	3.37e-05	0.000463	CcSEcCtD
Levonorgestrel—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.37e-05	0.000463	CcSEcCtD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.37e-05	0.00261	CbGpPWpGaD
Levonorgestrel—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.36e-05	0.000462	CcSEcCtD
Levonorgestrel—Headache—Cyclosporine—systemic lupus erythematosus	3.35e-05	0.00046	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	3.35e-05	0.00259	CbGpPWpGaD
Levonorgestrel—Anaemia—Methotrexate—systemic lupus erythematosus	3.35e-05	0.00046	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	3.35e-05	0.00259	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—TYK2—systemic lupus erythematosus	3.34e-05	0.00259	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.32e-05	0.000456	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.32e-05	0.000456	CcSEcCtD
Levonorgestrel—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.32e-05	0.000456	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	3.3e-05	0.00256	CbGpPWpGaD
Levonorgestrel—Testosterone—ALB—systemic lupus erythematosus	3.3e-05	0.0474	CrCbGaD
Levonorgestrel—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.3e-05	0.000453	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.29e-05	0.000452	CcSEcCtD
Levonorgestrel—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.29e-05	0.000452	CcSEcCtD
Levonorgestrel—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.29e-05	0.000452	CcSEcCtD
Levonorgestrel—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.27e-05	0.000449	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—systemic lupus erythematosus	3.25e-05	0.000447	CcSEcCtD
Levonorgestrel—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.25e-05	0.000447	CcSEcCtD
Levonorgestrel—Urticaria—Betamethasone—systemic lupus erythematosus	3.23e-05	0.000443	CcSEcCtD
Levonorgestrel—Urticaria—Dexamethasone—systemic lupus erythematosus	3.23e-05	0.000443	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.22e-05	0.000443	CcSEcCtD
Levonorgestrel—Dizziness—Prednisolone—systemic lupus erythematosus	3.22e-05	0.000442	CcSEcCtD
Levonorgestrel—Asthenia—Triamcinolone—systemic lupus erythematosus	3.21e-05	0.000441	CcSEcCtD
Levonorgestrel—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.21e-05	0.000441	CcSEcCtD
Levonorgestrel—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.000441	CcSEcCtD
Levonorgestrel—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.000441	CcSEcCtD
Levonorgestrel—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.21e-05	0.000441	CcSEcCtD
Levonorgestrel—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.2e-05	0.00044	CcSEcCtD
Levonorgestrel—Insomnia—Prednisone—systemic lupus erythematosus	3.2e-05	0.00044	CcSEcCtD
Levonorgestrel—Nausea—Cyclosporine—systemic lupus erythematosus	3.18e-05	0.000437	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	3.18e-05	0.00246	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—CDKN1B—systemic lupus erythematosus	3.17e-05	0.00246	CbGpPWpGaD
Levonorgestrel—Pruritus—Triamcinolone—systemic lupus erythematosus	3.17e-05	0.000435	CcSEcCtD
Levonorgestrel—Cough—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000434	CcSEcCtD
Levonorgestrel—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.16e-05	0.000434	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.15e-05	0.00244	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SNRPD1—systemic lupus erythematosus	3.15e-05	0.00244	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	3.14e-05	0.00244	CbGpPWpGaD
Levonorgestrel—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.14e-05	0.000432	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.14e-05	0.00243	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—EP300—systemic lupus erythematosus	3.12e-05	0.00242	CbGpPWpGaD
Levonorgestrel—Dyspepsia—Prednisone—systemic lupus erythematosus	3.11e-05	0.000428	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—IL2—systemic lupus erythematosus	3.1e-05	0.0024	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CDKN1B—systemic lupus erythematosus	3.1e-05	0.0024	CbGpPWpGaD
Levonorgestrel—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.1e-05	0.000426	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	3.09e-05	0.00239	CbGpPWpGaD
Levonorgestrel—Myalgia—Methotrexate—systemic lupus erythematosus	3.08e-05	0.000424	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—systemic lupus erythematosus	3.08e-05	0.000424	CcSEcCtD
Levonorgestrel—Decreased appetite—Prednisone—systemic lupus erythematosus	3.07e-05	0.000422	CcSEcCtD
Levonorgestrel—Rash—Prednisolone—systemic lupus erythematosus	3.07e-05	0.000422	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisolone—systemic lupus erythematosus	3.06e-05	0.000421	CcSEcCtD
Levonorgestrel—AR—Androgen receptor signaling pathway—CDKN1A—systemic lupus erythematosus	3.06e-05	0.00237	CbGpPWpGaD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000421	CcSEcCtD
Levonorgestrel—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.05e-05	0.00042	CcSEcCtD
Levonorgestrel—Fatigue—Prednisone—systemic lupus erythematosus	3.05e-05	0.000419	CcSEcCtD
Levonorgestrel—Headache—Prednisolone—systemic lupus erythematosus	3.05e-05	0.000419	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—systemic lupus erythematosus	3.05e-05	0.000419	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL2—systemic lupus erythematosus	3.03e-05	0.00235	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.03e-05	0.00234	CbGpPWpGaD
Levonorgestrel—Constipation—Prednisone—systemic lupus erythematosus	3.02e-05	0.000416	CcSEcCtD
Levonorgestrel—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.02e-05	0.000415	CcSEcCtD
Levonorgestrel—Rash—Hydrocortisone—systemic lupus erythematosus	3e-05	0.000412	CcSEcCtD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	2.99e-05	0.00232	CbGpPWpGaD
Levonorgestrel—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.99e-05	0.000411	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—JAK1—systemic lupus erythematosus	2.98e-05	0.00231	CbGpPWpGaD
Levonorgestrel—Headache—Hydrocortisone—systemic lupus erythematosus	2.98e-05	0.000409	CcSEcCtD
Levonorgestrel—Dizziness—Triamcinolone—systemic lupus erythematosus	2.96e-05	0.000407	CcSEcCtD
Levonorgestrel—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.95e-05	0.000406	CcSEcCtD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	2.95e-05	0.00229	CbGpPWpGaD
Levonorgestrel—Infection—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000403	CcSEcCtD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—systemic lupus erythematosus	2.92e-05	0.00227	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—EP300—systemic lupus erythematosus	2.92e-05	0.00226	CbGpPWpGaD
Levonorgestrel—Asthenia—Dexamethasone—systemic lupus erythematosus	2.91e-05	0.0004	CcSEcCtD
Levonorgestrel—Asthenia—Betamethasone—systemic lupus erythematosus	2.91e-05	0.0004	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000398	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.89e-05	0.000397	CcSEcCtD
Levonorgestrel—Nausea—Prednisolone—systemic lupus erythematosus	2.89e-05	0.000397	CcSEcCtD
Levonorgestrel—Pruritus—Dexamethasone—systemic lupus erythematosus	2.87e-05	0.000395	CcSEcCtD
Levonorgestrel—Pruritus—Betamethasone—systemic lupus erythematosus	2.87e-05	0.000395	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP9—systemic lupus erythematosus	2.87e-05	0.00222	CbGpPWpGaD
Levonorgestrel—Skin disorder—Methotrexate—systemic lupus erythematosus	2.87e-05	0.000394	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.86e-05	0.000393	CcSEcCtD
Levonorgestrel—PGR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.85e-05	0.00221	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MTA2—systemic lupus erythematosus	2.85e-05	0.0022	CbGpPWpGaD
Levonorgestrel—Vomiting—Triamcinolone—systemic lupus erythematosus	2.84e-05	0.000391	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—CDKN1B—systemic lupus erythematosus	2.84e-05	0.0022	CbGpPWpGaD
Levonorgestrel—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.84e-05	0.00039	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—RXRA—systemic lupus erythematosus	2.82e-05	0.00219	CbGpPWpGaD
Levonorgestrel—Nausea—Hydrocortisone—systemic lupus erythematosus	2.82e-05	0.000388	CcSEcCtD
Levonorgestrel—Rash—Triamcinolone—systemic lupus erythematosus	2.82e-05	0.000388	CcSEcCtD
Levonorgestrel—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.82e-05	0.000387	CcSEcCtD
Levonorgestrel—Anorexia—Methotrexate—systemic lupus erythematosus	2.82e-05	0.000387	CcSEcCtD
Levonorgestrel—Rash—Methylprednisolone—systemic lupus erythematosus	2.81e-05	0.000387	CcSEcCtD
Levonorgestrel—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.81e-05	0.000387	CcSEcCtD
Levonorgestrel—Urticaria—Prednisone—systemic lupus erythematosus	2.81e-05	0.000386	CcSEcCtD
Levonorgestrel—Headache—Triamcinolone—systemic lupus erythematosus	2.8e-05	0.000385	CcSEcCtD
Levonorgestrel—Headache—Methylprednisolone—systemic lupus erythematosus	2.8e-05	0.000384	CcSEcCtD
Levonorgestrel—Abdominal pain—Prednisone—systemic lupus erythematosus	2.79e-05	0.000384	CcSEcCtD
Levonorgestrel—Body temperature increased—Prednisone—systemic lupus erythematosus	2.79e-05	0.000384	CcSEcCtD
Levonorgestrel—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.78e-05	0.000382	CcSEcCtD
Levonorgestrel—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.78e-05	0.000382	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—EP300—systemic lupus erythematosus	2.72e-05	0.00211	CbGpPWpGaD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.69e-05	0.00037	CcSEcCtD
Levonorgestrel—Dizziness—Betamethasone—systemic lupus erythematosus	2.68e-05	0.000369	CcSEcCtD
Levonorgestrel—Dizziness—Dexamethasone—systemic lupus erythematosus	2.68e-05	0.000369	CcSEcCtD
Levonorgestrel—Insomnia—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000367	CcSEcCtD
Levonorgestrel—Nausea—Triamcinolone—systemic lupus erythematosus	2.66e-05	0.000365	CcSEcCtD
Levonorgestrel—Nausea—Methylprednisolone—systemic lupus erythematosus	2.65e-05	0.000364	CcSEcCtD
Levonorgestrel—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.63e-05	0.000362	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—systemic lupus erythematosus	2.63e-05	0.000361	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—CDKN1A—systemic lupus erythematosus	2.62e-05	0.00203	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.62e-05	0.00203	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.6e-05	0.000358	CcSEcCtD
Levonorgestrel—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.6e-05	0.000357	CcSEcCtD
Levonorgestrel—Vomiting—Dexamethasone—systemic lupus erythematosus	2.58e-05	0.000355	CcSEcCtD
Levonorgestrel—Vomiting—Betamethasone—systemic lupus erythematosus	2.58e-05	0.000355	CcSEcCtD
Levonorgestrel—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000353	CcSEcCtD
Levonorgestrel—Rash—Betamethasone—systemic lupus erythematosus	2.56e-05	0.000352	CcSEcCtD
Levonorgestrel—Rash—Dexamethasone—systemic lupus erythematosus	2.56e-05	0.000352	CcSEcCtD
Levonorgestrel—Dermatitis—Betamethasone—systemic lupus erythematosus	2.56e-05	0.000351	CcSEcCtD
Levonorgestrel—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.56e-05	0.000351	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.55e-05	0.000351	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—systemic lupus erythematosus	2.55e-05	0.00035	CcSEcCtD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	2.55e-05	0.00197	CbGpPWpGaD
Levonorgestrel—Headache—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.00035	CcSEcCtD
Levonorgestrel—Headache—Betamethasone—systemic lupus erythematosus	2.54e-05	0.00035	CcSEcCtD
Levonorgestrel—Asthenia—Prednisone—systemic lupus erythematosus	2.54e-05	0.000349	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—systemic lupus erythematosus	2.53e-05	0.000347	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—TNFSF13—systemic lupus erythematosus	2.52e-05	0.00195	CbGpPWpGaD
Levonorgestrel—Pruritus—Prednisone—systemic lupus erythematosus	2.5e-05	0.000344	CcSEcCtD
Levonorgestrel—PGR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	2.5e-05	0.00194	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SNRPB—systemic lupus erythematosus	2.44e-05	0.00189	CbGpPWpGaD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	2.43e-05	0.00188	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SNRPD1—systemic lupus erythematosus	2.42e-05	0.00188	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	2.42e-05	0.00188	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—TGFB1—systemic lupus erythematosus	2.42e-05	0.00188	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Prednisone—systemic lupus erythematosus	2.42e-05	0.000332	CcSEcCtD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.42e-05	0.00187	CbGpPWpGaD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	2.42e-05	0.00187	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.42e-05	0.000332	CcSEcCtD
Levonorgestrel—Nausea—Betamethasone—systemic lupus erythematosus	2.41e-05	0.000331	CcSEcCtD
Levonorgestrel—Nausea—Dexamethasone—systemic lupus erythematosus	2.41e-05	0.000331	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—TGFB1—systemic lupus erythematosus	2.37e-05	0.00183	CbGpPWpGaD
Levonorgestrel—Urticaria—Methotrexate—systemic lupus erythematosus	2.35e-05	0.000323	CcSEcCtD
Levonorgestrel—Dizziness—Prednisone—systemic lupus erythematosus	2.34e-05	0.000321	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000321	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000321	CcSEcCtD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.33e-05	0.00181	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—CD80—systemic lupus erythematosus	2.32e-05	0.0018	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	2.26e-05	0.00175	CbGpPWpGaD
Levonorgestrel—Vomiting—Prednisone—systemic lupus erythematosus	2.25e-05	0.000309	CcSEcCtD
Levonorgestrel—Rash—Prednisone—systemic lupus erythematosus	2.23e-05	0.000306	CcSEcCtD
Levonorgestrel—Dermatitis—Prednisone—systemic lupus erythematosus	2.23e-05	0.000306	CcSEcCtD
Levonorgestrel—Headache—Prednisone—systemic lupus erythematosus	2.21e-05	0.000304	CcSEcCtD
Levonorgestrel—ESR1—Gene Expression—MTA2—systemic lupus erythematosus	2.19e-05	0.0017	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.18e-05	0.000299	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.17e-05	0.00168	CbGpPWpGaD
Levonorgestrel—Asthenia—Methotrexate—systemic lupus erythematosus	2.12e-05	0.000291	CcSEcCtD
Levonorgestrel—Nausea—Prednisone—systemic lupus erythematosus	2.1e-05	0.000289	CcSEcCtD
Levonorgestrel—Pruritus—Methotrexate—systemic lupus erythematosus	2.09e-05	0.000287	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IL6—systemic lupus erythematosus	2.04e-05	0.00158	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	2.04e-05	0.00158	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.02e-05	0.000278	CcSEcCtD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.97e-05	0.00153	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.96e-05	0.00152	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—TYK2—systemic lupus erythematosus	1.96e-05	0.00152	CbGpPWpGaD
Levonorgestrel—Dizziness—Methotrexate—systemic lupus erythematosus	1.95e-05	0.000269	CcSEcCtD
Levonorgestrel—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	1.92e-05	0.00149	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	1.91e-05	0.00148	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	1.9e-05	0.00147	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.9e-05	0.00147	CbGpPWpGaD
Levonorgestrel—Vomiting—Methotrexate—systemic lupus erythematosus	1.88e-05	0.000258	CcSEcCtD
Levonorgestrel—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	1.87e-05	0.00145	CbGpPWpGaD
Levonorgestrel—Rash—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000256	CcSEcCtD
Levonorgestrel—AR—Gene Expression—SNRPB—systemic lupus erythematosus	1.86e-05	0.00144	CbGpPWpGaD
Levonorgestrel—Dermatitis—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000256	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	1.86e-05	0.00144	CbGpPWpGaD
Levonorgestrel—Headache—Methotrexate—systemic lupus erythematosus	1.85e-05	0.000254	CcSEcCtD
Levonorgestrel—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.84e-05	0.00143	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	1.81e-05	0.0014	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.8e-05	0.0014	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL6—systemic lupus erythematosus	1.78e-05	0.00138	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PPARG—systemic lupus erythematosus	1.78e-05	0.00138	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	1.76e-05	0.00137	CbGpPWpGaD
Levonorgestrel—Nausea—Methotrexate—systemic lupus erythematosus	1.76e-05	0.000241	CcSEcCtD
Levonorgestrel—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.72e-05	0.00134	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	1.67e-05	0.0013	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—CDKN1B—systemic lupus erythematosus	1.67e-05	0.00129	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.66e-05	0.00129	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	1.64e-05	0.00127	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—IL6—systemic lupus erythematosus	1.63e-05	0.00127	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—ALB—systemic lupus erythematosus	1.6e-05	0.00124	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.58e-05	0.00123	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.58e-05	0.00122	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	1.56e-05	0.00121	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.55e-05	0.0012	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—CDKN1A—systemic lupus erythematosus	1.54e-05	0.00119	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—NOS3—systemic lupus erythematosus	1.53e-05	0.00119	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.51e-05	0.00117	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.5e-05	0.00116	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.5e-05	0.00116	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—TNFSF13—systemic lupus erythematosus	1.48e-05	0.00115	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	1.47e-05	0.00114	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	1.47e-05	0.00114	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.47e-05	0.00114	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SNRPB—systemic lupus erythematosus	1.43e-05	0.00111	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTGS2—systemic lupus erythematosus	1.4e-05	0.00109	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TLR9—systemic lupus erythematosus	1.39e-05	0.00108	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	1.39e-05	0.00108	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.39e-05	0.00108	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.38e-05	0.00107	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.38e-05	0.00107	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—JUNB—systemic lupus erythematosus	1.37e-05	0.00106	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.35e-05	0.00105	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.33e-05	0.00103	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.28e-05	0.000995	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.28e-05	0.000993	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.28e-05	0.000988	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CSK—systemic lupus erythematosus	1.24e-05	0.000963	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.22e-05	0.000945	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.22e-05	0.000944	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—RXRA—systemic lupus erythematosus	1.2e-05	0.000932	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.2e-05	0.000931	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.2e-05	0.000926	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—EP300—systemic lupus erythematosus	1.17e-05	0.000903	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.15e-05	0.000895	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.15e-05	0.000892	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NCF2—systemic lupus erythematosus	1.14e-05	0.000881	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LYN—systemic lupus erythematosus	1.13e-05	0.000875	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.11e-05	0.000859	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NAT2—systemic lupus erythematosus	1.09e-05	0.000847	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—VDR—systemic lupus erythematosus	1.09e-05	0.000844	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.06e-05	0.000821	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.05e-05	0.000811	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—JUNB—systemic lupus erythematosus	1.05e-05	0.00081	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	9.9e-06	0.000767	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NR3C1—systemic lupus erythematosus	9.8e-06	0.00076	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—systemic lupus erythematosus	9.59e-06	0.000743	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	9.26e-06	0.000717	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RXRA—systemic lupus erythematosus	9.16e-06	0.00071	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.09e-06	0.000704	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JUNB—systemic lupus erythematosus	8.92e-06	0.000691	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.69e-06	0.000673	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.48e-06	0.000657	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—VDR—systemic lupus erythematosus	8.3e-06	0.000643	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRL—systemic lupus erythematosus	8.22e-06	0.000637	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TLR9—systemic lupus erythematosus	8.19e-06	0.000634	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—JUNB—systemic lupus erythematosus	8.05e-06	0.000624	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.93e-06	0.000614	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.82e-06	0.000606	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—systemic lupus erythematosus	7.59e-06	0.000588	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.49e-06	0.00058	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NR3C1—systemic lupus erythematosus	7.47e-06	0.000579	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CSK—systemic lupus erythematosus	7.3e-06	0.000565	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RXRA—systemic lupus erythematosus	7.06e-06	0.000547	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.84e-06	0.00053	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NCF2—systemic lupus erythematosus	6.67e-06	0.000517	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LYN—systemic lupus erythematosus	6.63e-06	0.000514	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JAK1—systemic lupus erythematosus	6.58e-06	0.000509	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.5e-06	0.000504	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—VDR—systemic lupus erythematosus	6.39e-06	0.000495	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR5—systemic lupus erythematosus	6.23e-06	0.000483	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.14e-06	0.000476	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—RXRA—systemic lupus erythematosus	6.13e-06	0.000475	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—C3—systemic lupus erythematosus	6.09e-06	0.000472	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—systemic lupus erythematosus	5.79e-06	0.000448	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NR3C1—systemic lupus erythematosus	5.75e-06	0.000446	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.69e-06	0.000441	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—F2—systemic lupus erythematosus	5.35e-06	0.000414	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.34e-06	0.000413	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JUNB—systemic lupus erythematosus	5.24e-06	0.000406	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CD80—systemic lupus erythematosus	5.13e-06	0.000397	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.98e-06	0.000386	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRL—systemic lupus erythematosus	4.83e-06	0.000374	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL2—systemic lupus erythematosus	4.76e-06	0.000369	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—systemic lupus erythematosus	4.46e-06	0.000345	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TYK2—systemic lupus erythematosus	4.33e-06	0.000335	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—systemic lupus erythematosus	4.25e-06	0.000329	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—systemic lupus erythematosus	3.87e-06	0.0003	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JAK1—systemic lupus erythematosus	3.86e-06	0.000299	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.68e-06	0.000285	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR5—systemic lupus erythematosus	3.66e-06	0.000283	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.6e-06	0.000279	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL2—systemic lupus erythematosus	3.6e-06	0.000279	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—C3—systemic lupus erythematosus	3.57e-06	0.000277	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—systemic lupus erythematosus	3.48e-06	0.00027	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—systemic lupus erythematosus	3.41e-06	0.000264	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.39e-06	0.000263	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—systemic lupus erythematosus	3.33e-06	0.000258	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EP300—systemic lupus erythematosus	3.23e-06	0.00025	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.19e-06	0.000247	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2—systemic lupus erythematosus	3.14e-06	0.000243	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.06e-06	0.000237	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—systemic lupus erythematosus	3.05e-06	0.000236	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CD80—systemic lupus erythematosus	3.01e-06	0.000233	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.81e-06	0.000218	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.8e-06	0.000217	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.54e-06	0.000197	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—EP300—systemic lupus erythematosus	2.53e-06	0.000196	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.49e-06	0.000193	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.16e-06	0.000167	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—systemic lupus erythematosus	2.12e-06	0.000164	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL2—systemic lupus erythematosus	2.11e-06	0.000164	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—systemic lupus erythematosus	2e-06	0.000155	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.99e-06	0.000154	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.9e-06	0.000147	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.8e-06	0.000139	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.79e-06	0.000139	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.65e-06	0.000128	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—systemic lupus erythematosus	1.24e-06	9.62e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.13e-06	8.75e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.02e-06	7.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	9.72e-07	7.53e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	8.89e-07	6.88e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	7.39e-07	5.73e-05	CbGpPWpGaD
